Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Peladawnon Jan 08, 2025 1:12pm
56 Views
Post# 36394560

RE:RE:RE:RE:RE:More dry powder…

RE:RE:RE:RE:RE:More dry powder…Everything you just said, and everything you have said is negative, in what you mistakenly think is your slick deceptive way that you mistakenly believe is actually fooling anyone.....most posters, including myself don't go by what is said on this or any other message board. They go by what the company is saying. .....the latest announcement says the company is gearing up for an "influential 2025".....does that sound to you like they getting ready to do a financing and dilution?.....perhaps you think they mean that they want to be "influential to the bottom line profits of some scumbag financier?.....like I said, you are fooling no one.....but go ahead and keep bashing....I'm gearing up to be influential to my continued purchasing of shares to support the future of this phenomenal new lifesaving cancer therapy.
<< Previous
Bullboard Posts
Next >>